Table 1. Clinicopathologic characteristics by stage of patients with PC at KNH 2014-2021.
Characteristics | Stage I/II | Stage III | Stage IV | p-value |
---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Age, mean (±SD), years | 55.8 (11.7) | 61.7 (11.2) | 58.7 (12.3) | 0.0509* |
Gender | ||||
Male | 17 (50.0) | 30 (44.8) | 60 (45.8) | 0.879† |
Female | 17 (50.0) | 37 (55.2) | 71 (54.2) | |
Location | ||||
Head | 33 (97.1) | 54 (80.6) | 100 (76.3) | 0.013∞ |
Body and tail | 1 (2.9) | 13 (19.4) | 31 (23.7) | |
Treatment | ||||
Surgical resection | 15 (44.1) | 2 (3.0) | 0 (0.0) | 0.000∞ |
Chemotherapy | 18 (52.9) | 24 (35.8) | 46 (35.1) | 0.162∞ |
Neoadjuvant | 9 (26.5) | 3 (4.5) | 0 (0.0) | |
Adjuvant | 7 (20.6) | 2 (2.9) | 0 (0.0) | |
Best supportive care only | 9 (26.5) | 42 (62.7) | 85 (64.9) | 0.000∞ |
*Anova; †Pearson chi-square; ∞Fisher’s exact